ECHS1 and colorectal cancer: Previous studies have indicated that branched-chain amino acids (BCAAs) in colorectal cancer enhance the acetylation of K204 in ECHS1, thereby impairing its ability to bind to enoyl-CoA and diminishing its catalytic activity.